West Pharmaceutical Services (WST) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $1.92.
- West Pharmaceutical Services' EPS (Weighted Average and Diluted) rose 378.38% to $1.92 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.75, marking a year-over-year increase of 14.84%. This contributed to the annual value of $6.49 for FY2024, which is 1769.35% down from last year.
- West Pharmaceutical Services' EPS (Weighted Average and Diluted) amounted to $1.92 in Q3 2025, which was up 378.38% from $1.82 recorded in Q2 2025.
- West Pharmaceutical Services' EPS (Weighted Average and Diluted)'s 5-year high stood at $2.48 during Q2 2022, with a 5-year trough of $1.23 in Q1 2025.
- In the last 5 years, West Pharmaceutical Services' EPS (Weighted Average and Diluted) had a median value of $1.85 in 2023 and averaged $1.89.
- In the last 5 years, West Pharmaceutical Services' EPS (Weighted Average and Diluted) soared by 11192.66% in 2021 and then crashed by 3116.88% in 2022.
- West Pharmaceutical Services' EPS (Weighted Average and Diluted) (Quarter) stood at $1.89 in 2021, then fell by 27.51% to $1.37 in 2022, then skyrocketed by 33.58% to $1.83 in 2023, then decreased by 5.02% to $1.74 in 2024, then increased by 10.46% to $1.92 in 2025.
- Its last three reported values are $1.92 in Q3 2025, $1.82 for Q2 2025, and $1.23 during Q1 2025.